Follow The Filings

WST Western Asset / Claymore Inf

Health Care, filed as WESTERN ASSET / CLAYMORE INF (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by WST's executives, directors and 10% owners in the last 12 months, from their Form 4s

All WST insider trades
  • None no insider bought on the open market
  • $3.9M sold by 2 insiders outside a trading plan
  • $2.7M sold by 1 insider under 10b5-1 plans
  1. Annette F Favorite Sr. VP & Chief HR Officer
    Planned sale
    $2.7M 7,524 shares at $355.03 26% of stake
    Traded Sep 11–15 Filed Sep 15
    ↗
  2. Annette F Favorite Sr. VP & Chief HR Officer
    Sale
    $2.8M 8,135 shares at $340.81 33% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  3. Annette F Favorite Sr. VP & Chief HR Officer
    Sale
    $860K 2,817 shares at $305.20 14% of stake
    Traded Apr 27 Filed Apr 29
    ↗
  4. Chad Winters VP, Chief Accounting Officer
    Sale
    $269K 896 shares at $300.67 37% of stake
    Traded Apr 27 Filed Apr 29
    ↗

Also filed in the last 12 months, not counted as buying or selling: 19 option exercises, 15 share withholdings for taxes, and 14 stock grants.

Congress

3 members of Congress traded WST in the last three years: 4 buys and 4 sales.

All Congress trades
  1. Lisa C. McClain R-MI-9Spouse Sell $1K–$15K Jul 22, 2025 filed Aug 13, 2025
  2. Lisa C. McClain R-MI-9Spouse Buy $1K–$15K Jun 17, 2025 filed Aug 13, 2025
  3. Robert P. Bresnahan, Jr. R-PA-8 Sell $1K–$15K Apr 8, 2025 filed May 8, 2025
  4. Robert P. Bresnahan, Jr. R-PA-8 Buy $1K–$15K Feb 25, 2025 filed Mar 27, 2025
  5. Jared Moskowitz D-FL-23Child Sell $1K–$15K Feb 13, 2025 filed Mar 6, 2025
  6. Jared Moskowitz D-FL-23 Sell $1K–$15K Nov 8, 2024 filed Dec 9, 2024

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K/A 1.05,9.01 Filing Doc
8-K 1.05,7.01,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.95B $2.89B $3.07B
Gross profit $1.13B $0.998B $1.1B
Gross margin * 38.3% 34.5% 35.9%
Net income $593.4M $492.7M $493.7M
Net margin * 20.1% 17.0% 16.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.94B $1.54B $1.98B
Total non-current assets * $1.89B $2.11B $2.29B
Total assets $3.83B $3.64B $4.27B
Total current liabilities $671.8M $550.4M $654.9M
Total non-current liabilities * $276.7M $410.7M $439.1M
Total equity $2.88B $2.68B $3.18B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $776.5M $653.4M $754.8M
Cash from investing -$368.7M -$378.7M -$285.9M
Cash from financing -$459.6M -$622.6M -$185.1M
Net change in cash -$40.4M -$369.3M $306.7M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.